Aktis Oncology Adds Glenn Gormley to Board

Aktis Oncology has appointed Glenn Gormley, MD, PhD, a veteran in research and development, to its Board of Directors. Gormley's extensive background in the oncology field is expected to provide valuable strategic guidance to the clinical-stage company. His expertise will be crucial as Aktis Oncology advances its pipeline and research initiatives. This appointment underscores the company's commitment to strengthening its leadership with seasoned industry professionals to drive innovation and development in cancer treatment.